Acasti Pharma (CVE:ACST) Trading 1.8% Higher

Acasti Pharma Inc. (CVE:ACSTGet Free Report)’s share price traded up 1.8% during mid-day trading on Wednesday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Trading Up 1.8 %

The stock has a market capitalization of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22. The firm has a 50-day moving average price of C$0.58 and a 200-day moving average price of C$0.58. The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52.

About Acasti Pharma

(Get Free Report)

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Recommended Stories

Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.